These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38101998)
1. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma. Sawlani V; Jen JP; Patel M; Jain M; Haq H; Ughratdar I; Wykes V; Nagaraju S; Watts C; Pohl U Clin Radiol; 2024 Mar; 79(3):197-204. PubMed ID: 38101998 [TBL] [Abstract][Full Text] [Related]
2. Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Cho NS; Sanvito F; Le VL; Oshima S; Teraishi A; Yao J; Telesca D; Raymond C; Pope WB; Nghiemphu PL; Lai A; Salamon N; Cloughesy TF; Ellingson BM Neuroradiology; 2024 Dec; 66(12):2153-2162. PubMed ID: 39377927 [TBL] [Abstract][Full Text] [Related]
3. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. Multimodal MRI and Han X; Xiao K; Bai J; Li F; Cui B; Cheng Y; Liu H; Lu J Diagnostics (Basel); 2024 Nov; 14(22):. PubMed ID: 39594235 [TBL] [Abstract][Full Text] [Related]
6. Comparison between contrast-enhanced fat-suppressed 3D FLAIR brain MR images and T2-weighted orbital MR images at 3 Tesla for the diagnosis of acute optic neuritis. Manasse S; Koskas P; Savatovsky J; Deschamps R; Vignal-Clermont C; Boudot de la Motte M; Papeix C; Trunet S; Lecler A Diagn Interv Imaging; 2024 Dec; 105(12):481-488. PubMed ID: 39242307 [TBL] [Abstract][Full Text] [Related]
7. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. Branzoli F; Liserre R; Deelchand DK; Poliani PL; Bielle F; Nichelli L; Sanson M; Lehéricy S; Marjańska M Radiology; 2023 Sep; 308(3):e223255. PubMed ID: 37668523 [TBL] [Abstract][Full Text] [Related]
8. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
9. Wernicke Encephalopathy: Typical and Atypical Findings in Alcoholics and Non-Alcoholics and Correlation with Clinical Symptoms. Arendt CT; Uckermark C; Kovacheva L; Lieschke F; Golbach R; Edwin Thanarajah S; Hattingen E; Weidauer S Clin Neuroradiol; 2024 Dec; 34(4):881-897. PubMed ID: 39014226 [TBL] [Abstract][Full Text] [Related]
10. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? van den Bent MJ; French PJ; Brat D; Tonn JC; Touat M; Ellingson BM; Young RJ; Pallud J; von Deimling A; Sahm F; Figarella Branger D; Huang RY; Weller M; Mellinghoff IK; Cloughsey TF; Huse JT; Aldape K; Reifenberger G; Youssef G; Karschnia P; Noushmehr H; Peters KB; Ducray F; Preusser M; Wen PY Neuro Oncol; 2024 Oct; 26(10):1805-1822. PubMed ID: 38912846 [TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma. Richardson TE; Walker JM; Hambardzumyan D; Brem S; Hatanpaa KJ; Viapiano MS; Pai B; Umphlett M; Becher OJ; Snuderl M; McBrayer SK; Abdullah KG; Tsankova NM Acta Neuropathol; 2024 Jul; 148(1):5. PubMed ID: 39012509 [TBL] [Abstract][Full Text] [Related]
12. Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score. Pellegrino F; Stabile A; Sorce G; Quarta L; Robesti D; Cannoletta D; Cirulli G; Barletta F; Scuderi S; Mazzone E; de Angelis M; Brembilla G; De Cobelli F; Salonia A; Montorsi F; Briganti A; Gandaglia G Eur Urol Focus; 2024 Jul; 10(4):634-640. PubMed ID: 37865591 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer. Bucher AM; Egger J; Dietz J; Strecker R; Hilbert T; Frodl E; Wenzel M; Penzkofer T; Hamm B; Chun FK; Vogl T; Kleesiek J; Beeres M J Imaging Inform Med; 2024 Dec; 37(6):3304-3315. PubMed ID: 38926263 [TBL] [Abstract][Full Text] [Related]
15. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients. Maung Myint T; Chong CH; von Huben A; Attia J; Webster AC; Blosser CD; Craig JC; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014839. PubMed ID: 39606952 [TBL] [Abstract][Full Text] [Related]
16. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
17. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
18. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021. Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557 [TBL] [Abstract][Full Text] [Related]
19. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
20. Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing. Noack D; Wach J; Barrantes-Freer A; Nicolay NH; Güresir E; Seidel C Acta Neuropathol Commun; 2024 Nov; 12(1):180. PubMed ID: 39593128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]